Popular Articles
Cellulite Cream

Sen. Graham Announces Support For Sotomayor As Republicans Continue To Weigh Votes
Sen. Lindsey Graham (R-S.C.) on Wednesday said he intends to vote for Supreme Court nominee Sonia Sotomayor, making him the fifth Republican senator to endorse the nominee, USA Today reports. Meanwhile, Senate Minority Whip Jon Kyl (R-Ariz.) became the 10th Republican to say that he will vote against her confirmation. During Sotomayor"s confirmation hearings last week, both Graham and Kyl "grilled her extensively," USA Today reports (Kiely/Brettschneider, USA Today, 7/23). According to Politico, Republicans privately estimate that Sotomayor could receive upward of 70 votes (Kady, Politico, 7/23). The Senate Judiciary Committee is scheduled to vote on the nomination Tuesday, followed by a full Senate vote late next week or the first week of August (Stanton, Roll Call, 7/22).According to CQ Today, Graham"s support could encourage other conservatives to back Sotomayor (Perine, CQ Today, 7/22). Graham said that Sotomayor "is definitely more liberal" than any Supreme Court nominee a Republican president would have chosen but that she also is "one of the most qualified" nominees in decades. He added, "I do believe that elections have consequences, and it"s not like we hid from the American people during the campaign that the Supreme Court nomination was at stake. The American people spoke" (USA Today, 7/23). Graham also said that he believes that Sotomayor "follows precedent" and "would not be an activist judge" (CQ Today, 7/22). He continued, "On balance, I do believe that the court will not dramatically change in terms of ideology with her selection," adding, "On some issues, quite frankly, (she) may be more balanced in her approach" (Hirschfeld Davis, AP/Boston Globe, 7/22).Kyl said, "Unfortunately, I have not been persuaded that Judge Sotomayor is absolutely committed to setting aside her biases and impartially deciding cases based upon the rule of law," adding, "And I cannot ignore her unwillingness to answer senators" questions straightforwardly" (Politico, 7/23).Broadcast Coverage NPR"s "All Things Considered" on Wednesday reported on Graham"s support of Sotomayor (Shapiro, "All Things Considered," NPR, 7/22).
generic viagra online
New Risk Factor Gene For Rheumatoid Arthritis Identified By Researchers
Scientists at The Feinstein Institute for Medical Research and a team of collaborators from across the country have identified a new risk factor gene for rheumatoid arthritis. The paper will be published in Nature Genetics and the finding brings light to the nature of the disease. The gene, dubbed REL, is a member of the NF-íºB family, important transcription factors that have many roles in the body. The NF-íºB family seems to have a big hand in regulating the body"s immune response as well.
News of the day
Full Senate To Begin Debate On Sotomayor Tuesday
The full Senate on Tuesday is set to begin debate on Supreme Court nominee Sonia Sotomayor, who is widely expected to be confirmed by the end of the week, the Los Angeles Times reports (Savage/Oliphant, Los Angeles Times, 8/4).Six Republicans have announced that they will vote to confirm Sotomayor, while most are aligning with the party base to vote against her confirmation. No Democrats have announced that they will oppose her nomination. At the risk of alienating his state"s large Hispanic population, Sen. John McCain (R-Ariz.) on Monday announced that he will oppose Sotomayor"s confirmation (AP/USA Today, 8/4). "An excellent resume and an inspiring life story are not enough to quality oneself for a lifetime of service on the Supreme Court," McCain said, adding, "I do not believe she shares my belief in judicial restraint" (Los Angeles Times, 8/4). Sen. Ben Nelson (D-Neb.), an advocate for gun-rights, had been under pressure to vote against her but on Monday said that he supports the nominee and will vote to confirm her. Nelson said that he believes Sotomayor has "a great respect for the law" (AP/USA Today, 8/4).
Oncology

Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)

Cobalis Corporation (OTC:CLSC) was recently awarded two additional International Patents in Canada and Mexico and has a patent pending application in Japan. PreHistin® is patented, safe for long-term daily use and available without a prescription. It is available in a cherry flavored, all natural, proprietary cyanocobalamin (vitamin B12) sub-lingual lozenge that is taken twice daily to regulate allergy sufferers" response to both indoor and outdoor allergens with daily and year round usage. Cobalis representatives indicate, "Cyanocobalamin has an excellent safety record, has been safety accepted by the US FDA, and has no upper dosage limits or contra-drug indications. For over 50 years the FDA has approved cyanocobalamin as a drug for anemia. Each PreHistin® lozenge contains 3.3mg Cyanocobalamin. For less than $1.00 per day, twice daily use of PreHistin® has been clinically shown to significantly increase serum vitamin B12 levels, making PreHistin® a cost effective and convenient alternative to other Vitamin B12 therapies, including needle injections." Cobalis Board Member, Dr. Kevin Prendiville states, "These new patents, in addition to the European Union, Australian and two U.S. patents further strengthen the value and assets of Cobalis Corporation intellectual properties. Furthermore, PreHistin®"s box, labeling and related box insert have been approved by DSHEA (Dietary Supplement Health and Education Act) regulation attorneys." About Cobalis Corp-Prehistin® "The World"s First Pre-Histamine" Headquartered in Irvine, California, Cobalis Corp. is an over the counter pharmaceutical and nutraceutical company. Its flagship product, PreHistin® is designed to prevent the primary causes of airborne allergies. PreHistin®, "The World"s First Pre-Histamine" is the only Phase III clinically tested sublingual product fully patented for long term and daily use without a prescription to help relieve allergy sufferers of both indoor and outdoor allergens. PreHistin® is manufactured by Monarch Nutraceutical Inc., a division of Nutraceutical Corporation in Ogden Utah. Nutraceutical Corp. (NUTR) was the original manufacturer of PreHistin® under the name Alleratin, which was distributed to thousands of allergy suffers without cost for compassionate use. Additional PreHistin® manufacturing partners include Marrs Printing, Walnut, CA and Merical Inc, Anaheim, CA. Domestic and international PreHistin® orders are currently fulfilled by International Sales and Marketing (ISM), Newark, NJ. For product information and ordering please visit at http://www.PreHistin.comor call toll free 1-877-4POLLEN. For additional company information please visit their website at http://www.Cobalis.com Cobalis Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):